NCT01767636View on ClinicalTrials.gov

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 16, 2013

Primary Completion Date

February 2, 2019

Study Completion Date

January 20, 2021

Conditions
Carcinoma of the Collecting Ducts of BelliniChromophobe Renal Cell CarcinomaKidney Medullary CarcinomaKidney OncocytomaMetastatic Renal Cell CancerPapillary Renal Cell CarcinomaRecurrent Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage IV Renal Cell Cancer
Interventions
DRUG

Pazopanib Hydrochloride

Given PO

Trial Locations (3)

55905

Mayo Clinic, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER